Therefore, the molecular mechanisms underlying ITGB5's dysregulation in AD with depression is worthy of further investigation, which could provide valuable insights into new therapeutic targets for complex neurodegenerative and psychiatric disorders. The gene discussed is ITGB5; the disease is Alzheimer disease.